Texas Lawmakers Examined Menopause Care Gaps

A state house subcommittee heard testimony on improving medical training and symptom management for menopausal women.

Updated on Oct. 6, 2026 in Women’s Health

Isometric editorial illustration of a clinical anatomical torso model sitting on a clean, empty examination table. — The Texas House subcommittee on Maternal Health, Menopause and Access to Evidence-Based Medicine met to address significant deficiencies in clinical menopause training. AI Illustration. Upload story photo >

Live Poll

Do you trust that medical professionals in your area are properly trained to treat menopause?

The Texas House subcommittee on Maternal Health, Menopause and Access to Evidence-Based Medicine held its second interim hearing to address significant deficiencies in menopause care. Lawmakers focused on the lack of standardized clinical training and the dismissal of symptoms reported by patients.

Why it matters

The hearing aimed to extend the state focus on women's health into midlife, addressing systemic gaps that have left many women without proper guidance. Experts highlighted that outdated medical research and inadequate school curricula contribute to these ongoing patient struggles.

A survey of residency directors found 93% support a standardized menopause curriculum, yet only 31% of programs currently offer one. Meanwhile, 60% of women report clinicians dismiss their symptoms, and 40% receive no treatment guidance.

The players

Texas House subcommittee on Maternal Health, Menopause and Access to Evidence-Based Medicine

This legislative body was formed in August 2026 to evaluate and improve women's healthcare delivery across the state.

Texas A&M University

The institution established a formal menopause gynecology elective and curriculum at its Family Medicine Residency in 2022.

The details

Testimony from OB/GYNs and specialists underscored a widespread reliance on outdated medical research and a lack of comprehensive training in medical schools. These findings follow the FDA decision earlier this year to remove black box warnings from hormone therapy labels, which officials cited as a positive step for modernizing care.

Texas A&M created a menopause curriculum in 2022.
The FDA began removing black box warnings from hormone therapy labels in February 2026.
The subcommittee on Maternal Health was established in August 2026.
The interim hearing took place on October 5, 2026.
The subcommittee will reconvene for the legislative session in January 2027.

Health Landscape

This hearing builds upon the regulatory progress initiated by the FDA black box warning removal to address broader clinical training gaps. It highlights a shift in focus from basic reproductive services to comprehensive, lifelong women's health needs.

Patients may find better access to care as medical schools are pressured to adopt standardized menopause training. These legislative efforts aim to ensure clinicians are better equipped to validate symptoms and provide accurate, modern treatment guidance.

The takeaway

Menopause care is currently undergoing a significant shift as lawmakers and medical professionals work to align clinical education with modern research. Patients are encouraged to advocate for their health needs while the medical community updates its approach to midlife wellness.